Richardson Peter C 4
4 · ANTARES PHARMA, INC. · Filed Jun 14, 2021
Insider Transaction Report
Form 4
Richardson Peter C
EVP, R&D Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-06-10+69,037→ 69,037 totalExercise: $4.42Exp: 2031-06-10→ Common Stock (69,037 underlying) - Award
Common Stock
2021-06-10$4.42/sh+36,199$160,000→ 36,199 total
Footnotes (3)
- [F1]Represents grant of restricted stock units made under the Antares Pharma, Inc. Equity Compensation Plan. The shares vest in three equal annual installments from the date of grant.
- [F2]Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan.
- [F3]The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date.